BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8718852)

  • 1. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
    Pisabarro MT; Serrano L
    Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reexamination of the recognition preference of the specificity pocket of the Abl SH3 domain.
    Santamaria F; Wu Z; Boulègue C; Pál G; Lu W
    J Mol Recognit; 2003; 16(3):131-8. PubMed ID: 12833568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
    Yamabhai M; Kay BK
    Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains.
    Chan DC; Bedford MT; Leder P
    EMBO J; 1996 Mar; 15(5):1045-54. PubMed ID: 8605874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal SH3 domain of p67phox binds its natural ligand in a reverse orientation.
    Finan P; Koga H; Zvelebil MJ; Waterfield MD; Kellie S
    J Mol Biol; 1996 Aug; 261(2):173-80. PubMed ID: 8757285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
    Hiipakka M; Poikonen K; Saksela K
    J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
    Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
    J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proline-rich sequences that bind to Src homology 3 domains with individual specificities.
    Alexandropoulos K; Cheng G; Baltimore D
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3110-4. PubMed ID: 7536925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
    Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries.
    Rickles RJ; Botfield MC; Weng Z; Taylor JA; Green OM; Brugge JS; Zoller MJ
    EMBO J; 1994 Dec; 13(23):5598-604. PubMed ID: 7988556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenesis of a buried polar interaction in an SH3 domain: sequence conservation provides the best prediction of stability effects.
    Maxwell KL; Davidson AR
    Biochemistry; 1998 Nov; 37(46):16172-82. PubMed ID: 9819209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of conserved interactions within the SH3 domain by alignment of sequences and structures.
    Larson SM; Davidson AR
    Protein Sci; 2000 Nov; 9(11):2170-80. PubMed ID: 11152127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
    Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
    J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the proline-rich region of mouse MAPKAP kinase 2: influence on catalytic properties and binding to the c-abl SH3 domain in vitro.
    Plath K; Engel K; Schwedersky G; Gaestel M
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1188-94. PubMed ID: 8093038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
    Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
    J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexibility of interdomain contacts revealed by topological isomers of bivalent consolidated ligands to the dual Src homology domain SH(32) of abelson.
    Xu Q; Zheng J; Xu R; Barany G; Cowburn D
    Biochemistry; 1999 Mar; 38(12):3491-7. PubMed ID: 10090735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.